1 Inhaled Nasal Influenza Vaccine Market Overview
    1.1 Product Overview and Scope of Inhaled Nasal Influenza Vaccine
    1.2 Inhaled Nasal Influenza Vaccine Segment by Type
        1.2.1 Global Inhaled Nasal Influenza Vaccine Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Live Attenuated Influenza Vaccine
        1.2.3 Split Influenza Vaccine
    1.3 Inhaled Nasal Influenza Vaccine Segment by Application
        1.3.1 Global Inhaled Nasal Influenza Vaccine Sales Comparison by Application: (2022-2028)
        1.3.2 3-17 Years
        1.3.3 Others
    1.4 Global Inhaled Nasal Influenza Vaccine Market Size Estimates and Forecasts
        1.4.1 Global Inhaled Nasal Influenza Vaccine Revenue 2017-2028
        1.4.2 Global Inhaled Nasal Influenza Vaccine Sales 2017-2028
        1.4.3 Inhaled Nasal Influenza Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Inhaled Nasal Influenza Vaccine Market Competition by Manufacturers
    2.1 Global Inhaled Nasal Influenza Vaccine Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Inhaled Nasal Influenza Vaccine Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Inhaled Nasal Influenza Vaccine Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Inhaled Nasal Influenza Vaccine Manufacturing Sites, Area Served, Product Type
    2.5 Inhaled Nasal Influenza Vaccine Market Competitive Situation and Trends
        2.5.1 Inhaled Nasal Influenza Vaccine Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Inhaled Nasal Influenza Vaccine Players Market Share by Revenue
        2.5.3 Global Inhaled Nasal Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Inhaled Nasal Influenza Vaccine Retrospective Market Scenario by Region
    3.1 Global Inhaled Nasal Influenza Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Inhaled Nasal Influenza Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Inhaled Nasal Influenza Vaccine Market Facts & Figures by Country
        3.3.1 North America Inhaled Nasal Influenza Vaccine Sales by Country
        3.3.2 North America Inhaled Nasal Influenza Vaccine Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Inhaled Nasal Influenza Vaccine Market Facts & Figures by Country
        3.4.1 Europe Inhaled Nasal Influenza Vaccine Sales by Country
        3.4.2 Europe Inhaled Nasal Influenza Vaccine Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Inhaled Nasal Influenza Vaccine Market Facts & Figures by Region
        3.5.1 Asia Pacific Inhaled Nasal Influenza Vaccine Sales by Region
        3.5.2 Asia Pacific Inhaled Nasal Influenza Vaccine Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 SEA
    3.6 Latin America Inhaled Nasal Influenza Vaccine Market Facts & Figures by Country
        3.6.1 Latin America Inhaled Nasal Influenza Vaccine Sales by Country
        3.6.2 Latin America Inhaled Nasal Influenza Vaccine Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Inhaled Nasal Influenza Vaccine Market Facts & Figures by Country
        3.7.1 Middle East and Africa Inhaled Nasal Influenza Vaccine Sales by Country
        3.7.2 Middle East and Africa Inhaled Nasal Influenza Vaccine Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Inhaled Nasal Influenza Vaccine Historic Market Analysis by Type
    4.1 Global Inhaled Nasal Influenza Vaccine Sales Market Share by Type (2017-2022)
    4.2 Global Inhaled Nasal Influenza Vaccine Revenue Market Share by Type (2017-2022)
    4.3 Global Inhaled Nasal Influenza Vaccine Price by Type (2017-2022)
5 Global Inhaled Nasal Influenza Vaccine Historic Market Analysis by Application
    5.1 Global Inhaled Nasal Influenza Vaccine Sales Market Share by Application (2017-2022)
    5.2 Global Inhaled Nasal Influenza Vaccine Revenue Market Share by Application (2017-2022)
    5.3 Global Inhaled Nasal Influenza Vaccine Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 AstraZeneca
        6.1.1 AstraZeneca Corporation Information
        6.1.2 AstraZeneca Description and Business Overview
        6.1.3 AstraZeneca Inhaled Nasal Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 AstraZeneca Inhaled Nasal Influenza Vaccine Product Portfolio
        6.1.5 AstraZeneca Recent Developments/Updates
    6.2 Cipla
        6.2.1 Cipla Corporation Information
        6.2.2 Cipla Description and Business Overview
        6.2.3 Cipla Inhaled Nasal Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Cipla Inhaled Nasal Influenza Vaccine Product Portfolio
        6.2.5 Cipla Recent Developments/Updates
    6.3 BCHT
        6.3.1 BCHT Corporation Information
        6.3.2 BCHT Description and Business Overview
        6.3.3 BCHT Inhaled Nasal Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 BCHT Inhaled Nasal Influenza Vaccine Product Portfolio
        6.3.5 BCHT Recent Developments/Updates
7 Inhaled Nasal Influenza Vaccine Manufacturing Cost Analysis
    7.1 Inhaled Nasal Influenza Vaccine Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Inhaled Nasal Influenza Vaccine
    7.4 Inhaled Nasal Influenza Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Inhaled Nasal Influenza Vaccine Distributors List
    8.3 Inhaled Nasal Influenza Vaccine Customers
9 Inhaled Nasal Influenza Vaccine Market Dynamics
    9.1 Inhaled Nasal Influenza Vaccine Industry Trends
    9.2 Inhaled Nasal Influenza Vaccine Market Drivers
    9.3 Inhaled Nasal Influenza Vaccine Market Challenges
    9.4 Inhaled Nasal Influenza Vaccine Market Restraints
10 Global Market Forecast
    10.1 Inhaled Nasal Influenza Vaccine Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Inhaled Nasal Influenza Vaccine by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Inhaled Nasal Influenza Vaccine by Type (2023-2028)
    10.2 Inhaled Nasal Influenza Vaccine Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Inhaled Nasal Influenza Vaccine by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Inhaled Nasal Influenza Vaccine by Application (2023-2028)
    10.3 Inhaled Nasal Influenza Vaccine Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Inhaled Nasal Influenza Vaccine by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Inhaled Nasal Influenza Vaccine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Inhaled Nasal Influenza Vaccine Sales Growth Rate Comparison by Type (2022-2028) & (K Dose) & (US$ Million)
    Table 2. Global Inhaled Nasal Influenza Vaccine Sales Growth Rate Comparison by Application (2022-2028) & (K Dose) & (US$ Million)
    Table 3. Global Inhaled Nasal Influenza Vaccine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Inhaled Nasal Influenza Vaccine Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Inhaled Nasal Influenza Vaccine Sales (K Dose) of Key Manufacturers (2017-2022)
    Table 6. Global Inhaled Nasal Influenza Vaccine Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Inhaled Nasal Influenza Vaccine Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Inhaled Nasal Influenza Vaccine Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Inhaled Nasal Influenza Vaccine Average Price (US$/Dose) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Inhaled Nasal Influenza Vaccine Manufacturing Sites and Area Served
    Table 11. Manufacturers Inhaled Nasal Influenza Vaccine Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Inhaled Nasal Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inhaled Nasal Influenza Vaccine as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Inhaled Nasal Influenza Vaccine Sales by Region (2017-2022) & (K Dose)
    Table 16. Global Inhaled Nasal Influenza Vaccine Sales Market Share by Region (2017-2022)
    Table 17. Global Inhaled Nasal Influenza Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Inhaled Nasal Influenza Vaccine Revenue Market Share by Region (2017-2022)
    Table 19. North America Inhaled Nasal Influenza Vaccine Sales by Country (2017-2022) & (K Dose)
    Table 20. North America Inhaled Nasal Influenza Vaccine Sales Market Share by Country (2017-2022)
    Table 21. North America Inhaled Nasal Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Inhaled Nasal Influenza Vaccine Revenue Market Share by Country (2017-2022)
    Table 23. Europe Inhaled Nasal Influenza Vaccine Sales by Country (2017-2022) & (K Dose)
    Table 24. Europe Inhaled Nasal Influenza Vaccine Sales Market Share by Country (2017-2022)
    Table 25. Europe Inhaled Nasal Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Inhaled Nasal Influenza Vaccine Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Inhaled Nasal Influenza Vaccine Sales by Region (2017-2022) & (K Dose)
    Table 28. Asia Pacific Inhaled Nasal Influenza Vaccine Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Inhaled Nasal Influenza Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Inhaled Nasal Influenza Vaccine Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Inhaled Nasal Influenza Vaccine Sales by Country (2017-2022) & (K Dose)
    Table 32. Latin America Inhaled Nasal Influenza Vaccine Sales Market Share by Country (2017-2022)
    Table 33. Latin America Inhaled Nasal Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Inhaled Nasal Influenza Vaccine Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Inhaled Nasal Influenza Vaccine Sales by Country (2017-2022) & (K Dose)
    Table 36. Middle East and Africa Inhaled Nasal Influenza Vaccine Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Inhaled Nasal Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Inhaled Nasal Influenza Vaccine Revenue Market Share by Country (2017-2022)
    Table 39. Global Inhaled Nasal Influenza Vaccine Sales by Type (2017-2022) & (K Dose)
    Table 40. Global Inhaled Nasal Influenza Vaccine Sales Market Share by Type (2017-2022)
    Table 41. Global Inhaled Nasal Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Inhaled Nasal Influenza Vaccine Revenue Share by Type (2017-2022)
    Table 43. Global Inhaled Nasal Influenza Vaccine Price by Type (2017-2022) & (US$/Dose)
    Table 44. Global Inhaled Nasal Influenza Vaccine Sales (K Dose) by Application (2017-2022)
    Table 45. Global Inhaled Nasal Influenza Vaccine Sales Market Share by Application (2017-2022)
    Table 46. Global Inhaled Nasal Influenza Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Inhaled Nasal Influenza Vaccine Revenue Share by Application (2017-2022)
    Table 48. Global Inhaled Nasal Influenza Vaccine Price by Application (2017-2022) & (US$/Dose)
    Table 49. AstraZeneca Corporation Information
    Table 50. AstraZeneca Description and Business Overview
    Table 51. AstraZeneca Inhaled Nasal Influenza Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 52. AstraZeneca Inhaled Nasal Influenza Vaccine Product
    Table 53. AstraZeneca Recent Developments/Updates
    Table 54. Cipla Corporation Information
    Table 55. Cipla Description and Business Overview
    Table 56. Cipla Inhaled Nasal Influenza Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 57. Cipla Inhaled Nasal Influenza Vaccine Product
    Table 58. Cipla Recent Developments/Updates
    Table 59. BCHT Corporation Information
    Table 60. BCHT Description and Business Overview
    Table 61. BCHT Inhaled Nasal Influenza Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 62. BCHT Inhaled Nasal Influenza Vaccine Product
    Table 63. BCHT Recent Developments/Updates
    Table 64. Production Base and Market Concentration Rate of Raw Material
    Table 65. Key Suppliers of Raw Materials
    Table 66. Inhaled Nasal Influenza Vaccine Distributors List
    Table 67. Inhaled Nasal Influenza Vaccine Customers List
    Table 68. Inhaled Nasal Influenza Vaccine Market Trends
    Table 69. Inhaled Nasal Influenza Vaccine Market Drivers
    Table 70. Inhaled Nasal Influenza Vaccine Market Challenges
    Table 71. Inhaled Nasal Influenza Vaccine Market Restraints
    Table 72. Global Inhaled Nasal Influenza Vaccine Sales Forecast by Type (2023-2028) & (K Dose)
    Table 73. Global Inhaled Nasal Influenza Vaccine Sales Market Share Forecast by Type (2023-2028)
    Table 74. Global Inhaled Nasal Influenza Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 75. Global Inhaled Nasal Influenza Vaccine Revenue Market Share Forecast by Type (2023-2028)
    Table 76. Global Inhaled Nasal Influenza Vaccine Sales Forecast by Application (2023-2028) & (K Dose)
    Table 77. Global Inhaled Nasal Influenza Vaccine Sales Market Share Forecast by Application (2023-2028)
    Table 78. Global Inhaled Nasal Influenza Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 79. Global Inhaled Nasal Influenza Vaccine Revenue Market Share Forecast by Application (2023-2028)
    Table 80. Global Inhaled Nasal Influenza Vaccine Sales Forecast by Region (2023-2028) & (K Dose)
    Table 81. Global Inhaled Nasal Influenza Vaccine Sales Market Share Forecast by Region (2023-2028)
    Table 82. Global Inhaled Nasal Influenza Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 83. Global Inhaled Nasal Influenza Vaccine Revenue Market Share Forecast by Region (2023-2028)
    Table 84. Research Programs/Design for This Report
    Table 85. Key Data Information from Secondary Sources
    Table 86. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Inhaled Nasal Influenza Vaccine
    Figure 2. Global Inhaled Nasal Influenza Vaccine Market Share by Type in 2021 & 2028
    Figure 3. Live Attenuated Influenza Vaccine Product Picture
    Figure 4. Split Influenza Vaccine Product Picture
    Figure 5. Global Inhaled Nasal Influenza Vaccine Market Share by Application in 2021 & 2028
    Figure 6. 3-17 Years
    Figure 7. Others
    Figure 8. Global Inhaled Nasal Influenza Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 9. Global Inhaled Nasal Influenza Vaccine Market Size (2017-2028) & (US$ Million)
    Figure 10. Global Inhaled Nasal Influenza Vaccine Sales (2017-2028) & (K Dose)
    Figure 11. Inhaled Nasal Influenza Vaccine Sales Share by Manufacturers in 2021
    Figure 12. Global Inhaled Nasal Influenza Vaccine Revenue Share by Manufacturers in 2021
    Figure 13. The Global 5 and 10 Largest Inhaled Nasal Influenza Vaccine Players: Market Share by Revenue in 2021
    Figure 14. Inhaled Nasal Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 15. Global Inhaled Nasal Influenza Vaccine Sales Market Share by Region (2017-2022)
    Figure 16. Global Inhaled Nasal Influenza Vaccine Sales Market Share by Region in 2021
    Figure 17. Global Inhaled Nasal Influenza Vaccine Revenue Market Share by Region (2017-2022)
    Figure 18. Global Inhaled Nasal Influenza Vaccine Revenue Market Share by Region in 2021
    Figure 19. United States Inhaled Nasal Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 20. Canada Inhaled Nasal Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Germany Inhaled Nasal Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. France Inhaled Nasal Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. U.K. Inhaled Nasal Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Italy Inhaled Nasal Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Russia Inhaled Nasal Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. China Inhaled Nasal Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Japan Inhaled Nasal Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. South Korea Inhaled Nasal Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. India Inhaled Nasal Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Australia Inhaled Nasal Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. SEA Inhaled Nasal Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Mexico Inhaled Nasal Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Brazil Inhaled Nasal Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Argentina Inhaled Nasal Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Turkey Inhaled Nasal Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Saudi Arabia Inhaled Nasal Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. UAE Inhaled Nasal Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Sales Market Share of Inhaled Nasal Influenza Vaccine by Type (2017-2022)
    Figure 39. Manufacturing Cost Structure of Inhaled Nasal Influenza Vaccine
    Figure 40. Manufacturing Process Analysis of Inhaled Nasal Influenza Vaccine
    Figure 41. Inhaled Nasal Influenza Vaccine Industrial Chain Analysis
    Figure 42. Channels of Distribution
    Figure 43. Distributors Profiles
    Figure 44. Bottom-up and Top-down Approaches for This Report
    Figure 45. Data Triangulation
    Figure 46. Key Executives Interviewed